Alhakamy N, Abdullah S, Md S, Ansari A, Bhattamisra S, Ibrahim I
Heliyon. 2024; 10(13):e34074.
PMID: 39071709
PMC: 11279758.
DOI: 10.1016/j.heliyon.2024.e34074.
Turac I, Porfire A, Iurian S, Crisan A, Casian T, Iovanov R
Pharmaceutics. 2024; 16(6).
PMID: 38931911
PMC: 11207633.
DOI: 10.3390/pharmaceutics16060790.
Matchimabura N, Praparatana R, Issarachot O, Oungbho K, Wiwattanapatapee R
Heliyon. 2024; 10(11):e31803.
PMID: 38841494
PMC: 11152664.
DOI: 10.1016/j.heliyon.2024.e31803.
Namikawa K, Bjornsson E
Int J Mol Sci. 2024; 25(10).
PMID: 38791497
PMC: 11122117.
DOI: 10.3390/ijms25105459.
Fungfoung K, Praparatana R, Issarachot O, Wiwattanapatapee R
Gels. 2023; 9(8).
PMID: 37623115
PMC: 10453886.
DOI: 10.3390/gels9080660.
State of Innovation in Alginate-Based Materials.
Adamiak K, Sionkowska A
Mar Drugs. 2023; 21(6).
PMID: 37367678
PMC: 10302983.
DOI: 10.3390/md21060353.
The Antibacterial Activities and Characterizations of Biosynthesized Zinc Oxide Nanoparticles, and Their Coated with Alginate Derived from .
Hamouda R, Alharbi A, Al-Tuwaijri M, Makharita R
Polymers (Basel). 2023; 15(10).
PMID: 37242910
PMC: 10221671.
DOI: 10.3390/polym15102335.
Foundations of gastrointestinal-based drug delivery and future developments.
Chu J, Traverso G
Nat Rev Gastroenterol Hepatol. 2021; 19(4):219-238.
PMID: 34785786
DOI: 10.1038/s41575-021-00539-w.
Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers.
Bunlung S, Nualnoi T, Issarachot O, Wiwattanapatapee R
Saudi Pharm J. 2021; 29(10):1143-1154.
PMID: 34703368
PMC: 8523354.
DOI: 10.1016/j.jsps.2021.08.005.
Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.
Vrettos N, Roberts C, Zhu Z
Pharmaceutics. 2021; 13(10).
PMID: 34683884
PMC: 8539558.
DOI: 10.3390/pharmaceutics13101591.
In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations.
Iglesias N, Galbis E, Romero-Azogil L, Benito E, Lucas R, Garcia-Martin M
Pharmaceutics. 2020; 12(7).
PMID: 32645909
PMC: 7408198.
DOI: 10.3390/pharmaceutics12070636.
The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector-Biocompatibility, Bioadhesiveness, and Biodegradability.
Martau G, Mihai M, Vodnar D
Polymers (Basel). 2019; 11(11).
PMID: 31717269
PMC: 6918388.
DOI: 10.3390/polym11111837.
Alginates: From the ocean to gastroesophageal reflux disease treatment.
Bor S, Kalkan I, Celebi A, Dincer D, Akyuz F, Dettmar P
Turk J Gastroenterol. 2019; 30(Suppl2):109-136.
PMID: 31624050
PMC: 6836317.
DOI: 10.5152/tjg.2019.19677.
The Safety and Tolerability of a Potential Alginate-Based Iron Chelator; Results of A Healthy Participant Study.
Horniblow R, Mistry P, Quraishi M, Beggs A, Van de Wiele T, Iqbal T
Nutrients. 2019; 11(3).
PMID: 30901846
PMC: 6471009.
DOI: 10.3390/nu11030674.
pH responsive alginate polymeric rafts for controlled drug release by using box behnken response surface design.
Abbas G, Hanif M, Khan M
Des Monomers Polym. 2018; 20(1):1-9.
PMID: 29491774
PMC: 5812168.
DOI: 10.1080/15685551.2016.1231046.
Medical Treatment of Gastroesophageal Reflux Disease.
Kroch D, Madanick R
World J Surg. 2017; 41(7):1678-1684.
PMID: 28321555
DOI: 10.1007/s00268-017-3954-2.
Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial.
Meteerattanapipat P, Phupong V
Sci Rep. 2017; 7:44830.
PMID: 28317885
PMC: 5357839.
DOI: 10.1038/srep44830.
Alginate-Iron Speciation and Its Effect on In Vitro Cellular Iron Metabolism.
Horniblow R, Dowle M, Iqbal T, Latunde-Dada G, Palmer R, Pikramenou Z
PLoS One. 2015; 10(9):e0138240.
PMID: 26378798
PMC: 4574481.
DOI: 10.1371/journal.pone.0138240.
Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells.
Wawer A, Harvey L, Dainty J, Perez-Moral N, Sharp P, Fairweather-Tait S
PLoS One. 2014; 9(11):e112144.
PMID: 25391138
PMC: 4229116.
DOI: 10.1371/journal.pone.0112144.
Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.
De Ruigh A, Roman S, Chen J, Pandolfino J, Kahrilas P
Aliment Pharmacol Ther. 2014; 40(5):531-7.
PMID: 25041141
PMC: 4343538.
DOI: 10.1111/apt.12857.